Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000230010 | SCV000290291 | likely benign | Adams-Oliver syndrome 5 | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697265 | SCV000534762 | likely benign | not provided | 2019-11-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001171093 | SCV000739405 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-02-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV001171093 | SCV001333771 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-10-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000230010 | SCV002554274 | likely benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270051 | SCV002554275 | likely benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330600 | SCV004039369 | benign | not specified | 2023-08-24 | criteria provided, single submitter | clinical testing |